Fabrication and characterization of core–shell TiO2-containing nanofibers of PCL-zein by coaxial electrospinning method as an erythromycin drug carrier

被引:0
作者
Mitra Baghali
Hakimeh Ziyadi
Reza Faridi-Majidi
机构
[1] Islamic Azad University,Active Pharmaceutical Ingredients Research Center, Tehran Medical Sciences
[2] Islamic Azad University,Department of Organic Chemistry, Faculty of Pharmaceutical Chemistry, Tehran Medical Sciences
[3] Tehran University of Medical Sciences,Department of Medical Nanotechnology, School of Advanced Technologies in Medicine
来源
Polymer Bulletin | 2022年 / 79卷
关键词
Core–shell nanofiber; Poly(caprolactone); Zein; Titanium dioxide; Erythromycin; Drug release;
D O I
暂无
中图分类号
学科分类号
摘要
As a novel transdermal delivery system, core–shell nanofibers exhibit a more controlled drug release than mono-structure nanofibers, especially when the hydrophilicity of core and shell polymers is different. Thus, this study aimed to produce biocompatible and antimicrobial erythromycin-loaded poly(caprolactone) (PCL/erythromycin) core with a zein-containing titanium dioxide (zein/TiO2) shell nanofibers. Accordingly, a specified concentration of PCL solution containing erythromycin and zein solution with titanium dioxide nanoparticle was prepared. Then, core–shell nanofibers were fabricated using co-axial electrospinning equipped with nozzles with different inner and outer diameters. The obtained morphology and diameter of core–shell nanofibers were characterized by scanning electron microscope (SEM) and were compared with the SEM images of PCL nanofibers, PCL/erythromycin nanofibers, zein nanofibers, zein/TiO2 nanofibers and PCL@zein core–shell nanofibers. The SEM images of PCL/erythromycin@zein/TiO2 nanofibers show that core–shell nanofibers are clearly fine, narrow, uniform and smooth without any adhesion with an average diameter of 625 nm. The core–shell structure of PCL@zein and PCL/erythromycin@zein/TiO2 nanofibers were confirmed by transmission electron microscope. The structure of nanofibers was approved by Fourier transform infrared and X-ray diffraction, showing the presence of PCL, zein, erythromycin and titanium dioxide in the obtained nanofibers. Moreover, UV–Vis spectroscopy was used to determine the in vitro drug release profile of erythromycin from prepared core–shell nanofibers, indicating the slow-release profile of the drug in 72 h. The antimicrobial properties of the core–shell nanofibers were considered by the zone of inhibition against Staphylococcus aureus, Bacillus cereus, Escherichia coli and Salmonella bacteria. The results showed that core–shell nanofibrous mats possess excellent antimicrobial activities.
引用
收藏
页码:1729 / 1749
页数:20
相关论文
共 361 条
[1]  
Folkman J(1966)Silicone rubber: a new diffusion property useful for general anesthesia Science 154 148-149
[2]  
Long DM(2018)Nanofiber in transmucosal drug delivery J Drug Deliv Sci Technol 43 379-387
[3]  
Rosenbaum R(2004)Drug delivery systems: entering the mainstream Science 303 1818-1822
[4]  
Deepak A(2004)Electronic MEMS for triggered delivery Adv Drug Deliv Rev 56 173-184
[5]  
Goyal AK(1998)Drug delivery and targeting Nature 392 5-10
[6]  
Rath G(2012)Responsive polymeric delivery systems Adv Drug Deliv Rev 64 327-341
[7]  
Allen TM(2019)Novel biocompatible poly(acrylamide)-grafted-dextran hydrogels: synthesis, characterization and biomedical applications J Microbiol Methods 159 200-210
[8]  
Cullis PR(2009)Impact of nanotechnology on drug delivery ACS Nano 3 16-20
[9]  
Grayson ACR(2012)Nanotechnology-based combinational drug delivery: an emerging approach for cancer therapy Drug Discov Today 17 1044-1052
[10]  
Shawgo RS(2007)Liposomal drugs dispersed in hydrogels. Effect of liposome, drug and gel properties on drug release kinetics Colloids Surf B Biointerfaces 55 212-221